Macrophage internal HIV-1 is protected from neutralizing antibodies.
about
The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages.The HIV-1 protein Vpr impairs phagosome maturation by controlling microtubule-dependent traffickingDynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connectionsBioinformatic analysis of HIV-1 entry and pathogenesis.The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitorAqueous extracts of the marine brown alga Lobophora variegata inhibit HIV-1 infection at the level of virus entry into cellsCritical role for the kinesin KIF3A in the HIV life cycle in primary human macrophagesOrganization and regulation of intracellular plasma membrane-connected HIV-1 assembly compartments in macrophages.CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells.High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.Tetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells.Mechanisms of Adaptive Immunity to Porcine Reproductive and Respiratory Syndrome VirusThe intracellular virus-containing compartments in primary human macrophages are largely inaccessible to antibodies and small molecules.Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.The intraviral protein interaction network of hepatitis C virus.A ubiquitin-specific protease possesses a decisive role for adenovirus replication and oncogene-mediated transformation.Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin-positive compartments that are accessible to broadly neutralizing antibodies.HIV-1 replication in human immune cells is independent of TAR DNA binding protein 43 (TDP-43) expression.Extracellular ATP induces the rapid release of HIV-1 from virus containing compartments of human macrophagesDynamic Association between HIV-1 Gag and Membrane Domains.The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell TransmissionSiglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1.Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins.Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques.Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsLentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis.The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection.HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A.Molecular Determinants Directing HIV-1 Gag Assembly to Virus-Containing Compartments in Primary Macrophages.Phagosome Migration and Velocity Measured in Live Primary Human Macrophages Infected with HIV-1.Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection.The role of Siglec-1 in HIV-1/macrophage interaction.Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.Dual role of the chromatin-binding factor PHF13 in the pre- and post-integration phases of HIV-1 replication.T cell-macrophage fusion triggers multinucleated giant cell formation for HIV-1 spreading.Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 and CD4 and Permissiveness to HIV-1 Infection.Myeloid Cell Interaction with HIV: A Complex Relationship.HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
P2860
Q27304947-3D971D25-4DBB-4293-834F-85044C145079Q27309574-B8713D05-6483-4571-BB97-12F7BB9F2582Q27311049-F2EAB85A-D94E-4F8C-8C1D-41E93F56B6B8Q27693321-076ADABE-BFA2-4F57-9B92-25F6414131C6Q28539308-9940DFFE-95D0-4C25-BB84-7024484474C8Q28542473-0A3E7CA6-42EB-45BE-8F6C-A3A4EF59A565Q30527789-B9C65BE2-F90C-49BD-84B1-8BE78AC2D116Q30543436-C49F7D8A-DB0D-4A8E-9C17-DC331C4A4CBEQ30557430-FB721C2F-23B8-464F-A5ED-826C8227FA7EQ30570557-3EFED06E-8C9F-4123-85B8-56C9BF77CF44Q31172123-34D14A91-FDDC-4E2F-AA2D-9A7C7540E40FQ32183108-C212255F-4D61-4AF6-929A-4BEC8F77B81BQ34261545-EE5A05B5-677D-4078-99C0-8857C240278CQ34303855-0EE02F31-E713-4C62-854D-F26A9EF3FEA2Q34418887-094B11C5-2B74-4F9C-8442-804FF502C9ACQ34649757-A173BD36-2E5B-4F1A-8F3F-0949461C205BQ35020445-78A5356C-7450-48A7-A7D0-51AD8B84D9AEQ35225635-7E06F209-776F-4CE4-A232-6D8DFC15EB2CQ35796263-F15B2A20-C607-46D8-99D9-6E6ED47696DDQ36102200-5DB3682D-485C-4059-BCC5-42D77221739AQ36123960-6D2A0A66-AF4C-49FD-8244-DD13184D7475Q36262599-950CD5EE-1FBF-4212-9842-1CD73F63CC52Q36528651-961829C1-F55E-404E-918F-4048D311E728Q36608554-FAAD8C32-FC29-4D7F-B054-8783575FC59EQ36989569-B3885C60-D381-4F1B-B4CC-C226884DC3D8Q37073330-7EBD8317-357E-41E6-A364-07EBA0FACE39Q37287774-D2DC1FE1-4C05-4788-B742-37CDA014885CQ37479957-4D6AC165-CF89-4EB1-961E-BDE096C40F40Q37683788-7D2A2C67-6DF4-403D-82D5-E9FD23C0E648Q39175785-746E3F79-94D9-4692-940A-8B5D6146D970Q39578041-FF0936B2-204C-4CAB-8B8B-8FC244DEBA22Q40523241-4D8C0C7E-EECE-492B-881F-B434C40196A5Q40623679-769B4C2D-DDBB-4015-B81A-C21619F35767Q40851567-545918A3-3B55-4841-8BFB-F8435F0F390DQ41557222-9F1DC2A7-73BA-4160-9774-FE6EE1195D2CQ41918811-969AA74C-3AD8-44EE-B9E2-2A9B50CF5F49Q41924135-423759DC-8E71-4DA9-9338-5B91E73A8133Q47141069-944A84FB-11A0-4FA5-BA55-A665E2E37FE5Q47141408-6A45EB7D-5163-4DEE-83A7-718AD0DE812BQ57030223-7183281F-3C75-4C6D-986E-A146F6D8B44B
P2860
Macrophage internal HIV-1 is protected from neutralizing antibodies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Macrophage internal HIV-1 is protected from neutralizing antibodies.
@ast
Macrophage internal HIV-1 is protected from neutralizing antibodies.
@en
type
label
Macrophage internal HIV-1 is protected from neutralizing antibodies.
@ast
Macrophage internal HIV-1 is protected from neutralizing antibodies.
@en
prefLabel
Macrophage internal HIV-1 is protected from neutralizing antibodies.
@ast
Macrophage internal HIV-1 is protected from neutralizing antibodies.
@en
P2093
P2860
P356
P1433
P1476
Macrophage internal HIV-1 is protected from neutralizing antibodies.
@en
P2093
Carina Banning
Carola Schneider
Heinrich Hohenberg
Herwig Koppensteiner
Michael Schindler
P2860
P304
P356
10.1128/JVI.05915-11
P577
2011-12-28T00:00:00Z